Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
University of Saskatchewan has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is handled by 1 distinct examiner, CHEN, STACY BROWN. As the busiest examiner, CHEN, STACY BROWN is responsible for 1 pending office action, the only one in the portfolio.
The portfolio is concentrated in 1 distinct art unit, reflecting a specific focus on biotechnological research. With 1 pending office action, the university's current engagement with the USPTO is limited to a single point of contact. The reliance on 1 distinct examiner means that the prosecution strategy should be tailored to the specific tendencies of CHEN, STACY BROWN.
This lack of examiner diversity simplifies the management of the 1 pending action within the 1 art unit. Practitioners can focus exclusively on the procedural requirements and substantive preferences of the assigned examiner. The alignment of 1 distinct art unit with 1 distinct examiner confirms that the prosecution is not currently spread across different specialized groups, allowing for a more streamlined path toward allowance.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHEN, STACY BROWN | 1 | 66.1% | +40.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18556668 | COMPOSITIONS AND METHODS FOR PREVENTING RSV AND PIV3 INFECTIONS | CHEN, STACY BROWN | — |
| Art Unit | Apps |
|---|---|
| 1672 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18556668 | COMPOSITIONS AND METHODS FOR PREVENTING RSV AND PIV3 INFECTIONS | CHEN, STACY BROWN | 1672 | §112 | Non-Final OA | — | Pending | Oct 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial